Marissa O'Callaghan Ireland

Dr Marissa O’Callaghan is a respiratory clinician–scientist specialising in interstitial lung disease (ILD), based at an academic centre in Dublin. She recently returned from Erasmus MC in Rotterdam, where she completed a postdoctoral clinical research fellowship. Her PhD focused on metabolic pathways and imaging biomarkers in pulmonary fibrosis, and her research spans ILD and rare lung diseases. Combining clinical cohorts, digital health monitoring and biomarker discovery, her work aims to improve understanding of disease progression. She is active in international research collaborations, academic mentoring and science communication, including the Irish Thoracic Society podcast series.
Job Title
Clinician-Scientist
Faculty / Department / Division
Dept of Pulmonology
Institution / Organisation
St Vincent's University Hospital, Dublin

21 November 2026, Saturday

Time Session
14:00
15:30
Amila Rathnapala Chairperson Sri Lanka
Gin Tsen Chai Chairperson Singapore
  • Marissa O'Callaghan Speaker Ireland
    Pulmonary alveolar proteinosis (PAP) is a rare but treatable cause of respiratory impairment that presents important diagnostic and therapeutic challenges. Using a case-based approach, this presentation will explore when to suspect PAP, how to confirm the diagnosis and distinguish its underlying causes, and when to consider treatment. It will highlight the roles of bronchoalveolar lavage and GM-CSF autoantibody testing, alongside practical approaches to assessing disease severity and progression. Established and emerging treatments, including whole-lung lavage and inhaled GM-CSF, will be discussed. Attendees will gain a practical framework for recognising PAP, initiating appropriate investigations and identifying patients who would benefit from specialist referral.
  • Moo Suk Park Speaker Republic of Korea
  • Q&A
Ballroom 3, Lower Ground Floor